Structural Heart Market Growth Report – Size & Share 2028

Structural Heart Market Forecast to 2028 - Global Analysis By Product (Occluders, Annuloplasty Rings, Heart Valve Balloons, and Others), Procedure (Heart Valve Stenosis, Heart Valve Regurgitation, and Left Atrial Appendage Closure), and End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Centers)

  • Report Code : TIPHE100001164
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 239
Buy Now

Structural Heart Market Growth Report – Size & Share 2028

Buy Now

[Research Report] The structural heart market was valued at US$ 14,245.55 million in 2022 and is expected to reach US$ 22,560.88 million by 2028; it is estimated to record a CAGR of 8.0% from 2022 to 2028.

The structural heart market is segmented on the basis of product, procedure, end user, and geography. The report offers insights and in-depth analysis of the market, emphasizing various parameters such as dynamics, trends, and opportunities of the market and competitive landscape analysis of leading market players across various regions. It also includes an analysis of the impact of the COVID-19 pandemic on the market across the regions.

Structural Heart Market, Market Insights

Rising Number of Cardiovascular Disease Cases and Training Programs Drive Structural Heart Market

According to the World Health Organization (WHO), cardiovascular diseases are the second leading cause of death worldwide. Therefore, various initiatives are being taken to control the incidence of cardiovascular diseases. Heart valve disease is one of the most common causes of heart failure. Degenerative diseases of aortic and mitral valves and diseases of dysfunctional tricuspid valves lead to a worse clinical course in severe cases. Minimally invasive, surgical, and catheter-based interventions for structural heart disease have increased dramatically recently. The UK Factsheet January 2022, published by the British Heart Foundation (BHF), shows that ~7.6 million people with cardiovascular diseases live in the UK. According to the same source, ~4 million men and ~3.6 million women were diagnosed with heart and circulatory diseases in the country in 2021. Owing to the high incidence of cardiovascular disease, there is a high demand for treatment procedures such as angioplasty and cardiac surgery for survival, which creates opportunities for companies to provide structural heart valves and annuloplasty rings, among other devices.

The structural heart is an evolving field consisting of heart valve surgeries and transcatheter procedures; therefore, various training programs are being arranged for cardiac surgeons and physicians. Over the past decade, the growing incidence of structural heart disease has necessitated the development of formal training programs to ensure the appropriate competency of workforces. The structure, length, and scope of training vary greatly between programs. Most programs provide effective training on transcatheter aortic valve replacement (TAVR) procedures, simultaneously providing a lesser and variable experience of atrial septal or ventricular septal defect closure and left atrial appendage closure interventions. With the advent of TAVR, the MitraClip mitral valve repair system (Abbott Vascular), and left atrial appendage occlusion (LAAO) procedures, there has been a significant increase in the volume of structural cardiac procedures performed for treating patients with complex cardiovascular conditions. Many organizations have developed services and procedural offerings in an organized format for the structural cardiac program to accommodate the influx of patients. Training in SHD is exciting, challenging, and rewarding overall. As the field evolves, standardization of SHD training becomes extremely important to ensure the best quality of patient care. A mentor can help navigate the numerous considerations outlined and can be the best asset to transition from training to practice successfully.

Following is the list of the training programs available in the US for the structural heart procedures:

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Structural Heart Market: Strategic Insights

Structural Heart Market

  • CAGR (2022 - 2028)
    8.0%
  • Market Size 2022
    US$ 14.25 Billion
  • Market Size 2028
    US$ 22.56 Billion

Market Dynamics

GROWTH DRIVERS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
FUTURE TRENDS
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX
OPPORTUNITIES
  • XXXXXXX
  • XXXXXXX
  • XXXXXXX

Key Players

  • ABBOTT
  • MEDTRONIC
  • BOSTON SCIENTIFIC CORPORATION
  • CRYOLIFE, INC
  • EDWARD LIFESCIENCES CORPORATION
  • LEPU MEDICAL
  • BRAILE BIOMEDICA
  • ARAN BIOMEDICAL TEORANTA
  • Micro Interventional Devices, Incorporated

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product
  • Occluders
  • Annuloplasty Rings
  • Heart Valve Balloons
  • Others
Procedure
  • Heart Valve Stenosis
  • Heart Valve Regurgitation
  • Left Atrial Appendage Closure
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Structural Heart Training Programs in the US

Sr. No

Program

State

1

University of Washington Program

Swedish Medical Center in Seattle, WA

Washington

2

Main Line Health System/Lankenau Medical Center Program

Thomas Jefferson University Hospital

Pennsylvania

3

New York Presbyterian Hospital (Columbia Campus) Program

NYU School of Medicine Langone Medical Center

Icahn School of Medicine at Mount Sinai

Lenox Hill Heart and Vascular Institute-Northwell Health

Montefiore Medical Center

The University at Buffalo – State University of New York

New York

4

Duke University Hospital Program

UNC Medical Center Program

North Carolina

5

Rutgers Robert Wood Johnson Medical School - New Brunswick, New Jersey

Structural and Congenital Heart Disease Fellowship Program at Hackensack University Medical Center and Joseph M Sanzari Children’s Hospital

Hackensack University Medical Center

New Jersey

6

Scripps Clinic/Scripps Green Hospital Program

Sharp Healthcare Advanced Interventional and Structural Heart Fellowship

University of California, Davis, Health Program

University of California, San Diego

University of California, San Francisco

California

7

University of Maryland Program

Johns Hopkins University Program

Maryland

8

William Beaumont Hospital Program

Detroit Medical Center/Wayne State University Program

Henry Ford Hospital/Wayne State University Program

Ascension Borgess—Michigan State University Program

Michigan Medicine—The University of Michigan Program

Michigan

9

Emory University Program

Georgia

10

Banner-University Medical Center Phoenix Program

Tucson Medical Center/THMEP

Arizona

Source: The Society for Cardiovascular Angiography and Interventions (SCAI)

Therefore, the burgeoning number of cardiovascular disease cases and training programs on structural heart are fueling the structural heart market growth.

Product-Based Insights

Based on product, the structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. In 2022, the occluders segment held the largest share of the structural heart market; however, the annuloplasty rings segment is anticipated to register the highest CAGR during the forecast period. Occluders are one of the most commonly used products owing to the rising prevalence of congenital heart defects such as atrial septum defect, ventricular septum defect, patent ductus arteriosus, and patent foramen ovale. Occluders help in the treatment of congenital heart defects through minimally invasive procedures, which provide easy treatment options and speedy recovery to the patients.

Structural Heart Market, By Procedure-Based Insights

Based on procedure, the structural heart market is segmented into heart valve stenosis, heart valve replacement, and left atrial appendage closure. In 2022, the aortic valve stenosis segment held the largest market share of the structural heart market. However, the left atrial appendage closure segment is anticipated to register the highest CAGR during the forecast period.

Structural Heart Market Report Scope

Report Attribute Details
Market size in 2022 US$ 14.25 Billion
Market Size by 2028 US$ 22.56 Billion
Global CAGR (2022 - 2028) 8.0%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Product
  • Occluders
  • Annuloplasty Rings
  • Heart Valve Balloons
  • Others
By Procedure
  • Heart Valve Stenosis
  • Heart Valve Regurgitation
  • Left Atrial Appendage Closure
By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • ABBOTT
  • MEDTRONIC
  • BOSTON SCIENTIFIC CORPORATION
  • CRYOLIFE, INC
  • EDWARD LIFESCIENCES CORPORATION
  • LEPU MEDICAL
  • BRAILE BIOMEDICA
  • ARAN BIOMEDICAL TEORANTA
  • Micro Interventional Devices, Incorporated
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Structural Heart Market, By End User-Based Insights

    Based on end user, the structural heart market is segmented into hospitals, ambulatory surgical centers, and cardiac centers. The hospitals segment held the largest share of the structural heart market in 2022 and is expected to record the highest CAGR during the forecast period.

    The structural heart market players adopt organic strategies, such as product launch and expansion, to expand their footprint and product portfolio across the world and meet the growing demand. Inorganic growth strategies witnessed in the market are partnerships and collaborations. These growth strategies have allowed the market players to expand their businesses and enhance their geographic presence. Additionally, acquisitions, partnerships, and other growth strategies help strengthen the company’s customer base and increase its product portfolio.

    • In February 2023, Medtronic relaunched its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT).
    • In November 2022, Boston Scientific Corporation released the first results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) study evaluating the performance of the ACURATE neo2TM Aortic Valve System. The findings, which included a high procedural success rate of 98.4% and low mortality rates and paravalvular leak (PVL), were presented during a late-breaking clinical trial session at PCR London Valves 2022.
    • In October 2022, The Guangzhou Women and Children's Medical Center team successfully implanted Memosorb for a child with congenital heart disease. The successful completion of this operation marks the clinical application of the occluder has taken an essential step in South China, which once again confirms the safety and effectiveness of the Memosorb in the interventional treatment of congenital heart disease.

    Structural Heart Market, Company Profiles

    • Abbott Laboratories
    • Medtronic Plc
    • Boston Scientific Corp
    • Artivion Inc.
    • Edwards Lifesciences Corp
    • Lepu Medical Technology Beijing Co Ltd
    • Braile Biomédica Industry
    • Commerce and Representations Ltd
    • Aran Biomedical Teoranta
    • Micro Interventional Devices Inc
    • Corcym UK Ltd.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Product, Procedure, and End User

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

    Frequently Asked Questions


    Which segment is dominating the structural heart market?

    The structural heart market, by product, is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest market share in 2022, however, annuloplasty rings is anticipated to register the highest CAGR in the market during the forecast period.

    What will be the CAGR of the structural heart market during the forecast period?

    The market is estimated to grow at a CAGR of 8.0% during the forecast period.

    What are the driving factors for the structural heart market across the world?

    The factors driving the structural heart market growth, includes innovative structural heart services, and a rise in the number of cardiovascular procedures and corresponding training programs boost the market growth.

    What is the structural heart market?

    Structural heart disease is a non-coronary defect of the heart, thus not affecting the blood vessels in the heart. Most structural heart conditions are present since birth (congenital), but these can also be acquired later in life owing to wear & tear from infection. Advancements in the medical field have replaced open-heart surgical procedures with minimally invasive procedures. The devices that are used in structural heart disease comprise replacement and repair devices, such as devices that are used for the treatment of heart-related diseases. Structural heart devices comprise annuloplasty rings and heart valve balloons occluders, among others.

    Who are the major players in the structural heart market?

    The structural heart market majorly consists of the players, such as Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc., Edwards Lifesciences Corp, Lepu Medical Technology Beijing Co Ltd, Braile Biomédica Industry, Commerce and Representations Ltd, Aran Biomedical Teoranta, Micro Interventional Devices Inc, Corcym UK Ltd.

    What was the structural heart market size in 2022?

    The structural heart market was valued at US$ 14,245.55 million in 2022.

    What are the growth estimates for the structural heart market till 2028?

    The structural heart market is expected to be valued at US$ 22,560.88 million in 2028.

    The List of Companies - Structural Heart Market

    1. ABBOTT
    2. MEDTRONIC
    3. BOSTON SCIENTIFIC CORPORATION
    4. CRYOLIFE, INC
    5. EDWARD LIFESCIENCES CORPORATION
    6. LEPU MEDICAL
    7. BRAILE BIOMEDICA
    8. ARAN BIOMEDICAL TEORANTA
    9. Micro Interventional Devices, Incorporated
    10. CORCYM

    Trends and growth analysis reports related to Medical Device : READ MORE..